SCHEMBL10023027

SCHEMBL10023027

CNN1CCCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24733071 1.00
SCHEMBL9222113 0.92
SCHEMBL24108670 0.90 GAA (0.33)
SCHEMBL21183414 0.83
SCHEMBL23182956 0.77
SCHEMBL4907901 0.75 MGLL (0.31)
SCHEMBL24465005 0.73
SCHEMBL2532934 0.73
SCHEMBL3198184 0.72
SCHEMBL1851130 0.70 GAA (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023135265-A1 MOLECULES TARGETING VIRAL RNA AND/OR VIRAL RNA-PROTEIN COMPLEXES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS, IN PARTICULAR COVID-19 Johann Wolfgang Goethe-Universität Frankfurt am Main (DE) 2023-07-20 WO disclosed
WO-2023280026-A1 HETEROAROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2023-01-12 WO disclosed
EP-3677588-A1 MODIFIED OLIGONUCLEOTIDES AND COMPOUND THAT CAN BE USED FOR SYNTHESIZING SAME Guangzhou Ribobio Co., Ltd. (CN) 2020-07-08 EP disclosed
WO-2012016362-A1 Β-SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE AND USES THEREOF 中国人民解放军军事医学科学院毒物药物研究所 (CN) 2012-02-09 WO disclosed